Serina Therapeutics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Serina Therapeutics, Inc. (SER) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$1.40 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2024-08-09
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-06-30 was -$2.04M.
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-03-31 was $644.00K, a 174.04% increase year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-12-31 was $579.00K, a 139.26% increase year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-09-30 was $386.00K, a 254.13% increase year-over-year.
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.15M, a 698.61% increase from fiscal 2022.
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $144.00K.
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was -$772.00K, a 302.09% decline from fiscal 2020.
- Serina Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $382.00K, a 126.04% increase from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | -$2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.40M 10-Q · filed 2024-08-09 | -$819.00K derived: sum of 3 quarters · filed 2024-08-09 | -$433.00K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2024-03-31 | $644.00K 10-Q · filed 2024-05-14 | $1.22M derived: sum of 2 quarters · filed 2024-05-14 | $1.61M derived: sum of 3 quarters · filed 2024-05-14 | $1.56M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-12-31 | $579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $965.00K derived: sum of 2 quarters · filed 2024-03-22 | $915.00K derived: sum of 3 quarters · filed 2024-08-09 | $1.15M 10-K · filed 2024-03-22 | ||||
| 2023-09-30 | $386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $336.00K derived: sum of 2 quarters · filed 2024-08-09 | $571.00K 10-Q · filed 2023-11-14 | $813.00K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $185.00K 10-Q · filed 2024-08-09 | -$96.00K 10-Q · filed 2023-08-14 | $427.00K derived: sum of 3 quarters · filed 2024-08-09 | $536.00K derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | $235.00K 10-Q · filed 2024-05-14 | $205.00K 10-Q · filed 2023-05-12 | $477.00K derived: sum of 2 quarters · filed 2024-05-14 | $586.00K derived: sum of 3 quarters · filed 2024-05-14 | $172.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $351.00K derived: sum of 2 quarters · filed 2024-03-22 | -$63.00K derived: sum of 3 quarters · filed 2024-03-22 | $144.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$305.00K derived: sum of 2 quarters · filed 2023-11-14 | -$98.00K 10-Q · filed 2023-11-14 | -$251.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$414.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$207.00K 10-Q · filed 2023-08-14 | -$360.00K derived: sum of 3 quarters · filed 2023-08-14 | -$737.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $207.00K 10-Q · filed 2023-05-12 | $54.00K derived: sum of 2 quarters · filed 2023-05-12 | -$323.00K derived: sum of 3 quarters · filed 2023-05-12 | -$219.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$530.00K derived: sum of 2 quarters · filed 2023-03-31 | -$426.00K derived: sum of 3 quarters · filed 2023-03-31 | -$772.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$273.00K derived: sum of 2 quarters · filed 2022-11-10 | -$619.00K 10-Q · filed 2022-11-10 | -$466.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$242.00K 10-Q · filed 2022-08-12 | -$89.00K derived: sum of 3 quarters · filed 2022-08-12 | $39.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$346.00K 10-Q · filed 2022-05-13 | -$193.00K derived: sum of 2 quarters · filed 2022-05-13 | -$65.00K derived: sum of 3 quarters · filed 2022-05-13 | -$309.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $281.00K derived: sum of 2 quarters · filed 2022-03-29 | $37.00K derived: sum of 3 quarters · filed 2022-03-29 | $382.00K 10-K · filed 2022-03-29 | $340.00K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$116.00K derived: sum of 2 quarters · filed 2021-11-12 | $229.00K 10-Q · filed 2021-11-12 | $237.00K 10-Q · filed 2020-11-16 | $79.00K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $101.00K 10-Q · filed 2021-08-13 | $186.00K 10-Q · filed 2020-08-14 | -$49.00K derived: sum of 3 quarters · filed 2021-08-13 | $149.00K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $345.00K 10-Q · filed 2021-05-17 | $494.00K 10-Q · filed 2020-05-14 | $195.00K derived: sum of 2 quarters · filed 2021-05-17 | $393.00K derived: sum of 3 quarters · filed 2021-05-17 | $566.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $48.00K derived: sum of 2 quarters · filed 2021-03-31 | $221.00K derived: sum of 3 quarters · filed 2021-03-31 | $169.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $371.00K derived: sum of 2 quarters · filed 2020-11-16 | $319.00K 10-Q · filed 2020-11-16 | $726.00K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $121.00K 10-Q · filed 2020-08-14 | $528.00K derived: sum of 3 quarters · filed 2020-08-14 | $619.00K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$52.00K 10-Q · filed 2020-05-14 | $355.00K derived: sum of 2 quarters · filed 2020-05-14 | $446.00K derived: sum of 3 quarters · filed 2020-05-14 | $314.00K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $407.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $498.00K derived: sum of 2 quarters · filed 2020-03-31 | $366.00K derived: sum of 3 quarters · filed 2020-03-31 | $648.00K 10-K/A · filed 2020-03-31 | ||||
| 2018-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$41.00K derived: sum of 2 quarters · filed 2019-11-14 | $241.00K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | -$132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $150.00K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $282.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $267.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |